Interestingly, there was minimal overlap observed among the Myc‐signatured metabolic pathways mentioned above, indicating that c‐myc exerts regulatory control over these metabolic processes not through a singular major signaling pathway, but rather by functioning as a comprehensive upstream switch for multiple signaling pathways, which suggests c‐myc might be a promising cancer therapeutic target for cancer treatment. This evidence concerns the gene MYC and cancer.